METFORMIN HYDROCHLORIDE
( DrugBank: Metformin, Metformin hydrochloride / KEGG DRUG: Metformin hydrochloride, Metformin, Metformin hydrochloride, Metformin )
5 diseases
| 告示番号 | 疾患名(ページ内リンク) | 臨床試験数 |
|---|---|---|
| 81 | 先天性副腎皮質酵素欠損症 | 1 |
| 158 | 結節性硬化症 | 1 |
| 265 | 脂肪萎縮症 | 1 |
81. 先天性副腎皮質酵素欠損症
臨床試験数 : 107 / 薬物数 : 101 - (DrugBank : 24) / 標的遺伝子数 : 14 - 標的パスウェイ数 : 71
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
158. 結節性硬化症
臨床試験数 : 132 / 薬物数 : 91 - (DrugBank : 22) / 標的遺伝子数 : 41 - 標的パスウェイ数 : 119
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
265. 脂肪萎縮症
臨床試験数 : 133 / 薬物数 : 176 - (DrugBank : 58) / 標的遺伝子数 : 30 - 標的パスウェイ数 : 102
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
299. 嚢胞性線維症
臨床試験数 : 1,885 / 薬物数 : 1,782 - (DrugBank : 252) / 標的遺伝子数 : 110 - 標的パスウェイ数 : 190
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
301. 黄斑ジストロフィー
臨床試験数 : 69 / 薬物数 : 66 - (DrugBank : 15) / 標的遺伝子数 : 10 - 標的パスウェイ数 : 80
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
